Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2025
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.5281/zenodo.17998913 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901244832907264 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Specific cross-titration schedules for switching from fluoxetine to mirtazapine are not detailed in available evidence, highlighting the need for clinical judgment based on pharmacokinetic properties and patient factors. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17998913 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | How should I switch a patient from fluoxetine 40mg to mirtazapine 15mg? Please provide the complete cross-titration schedule. Tripdatabase switch patient fluoxetine 40mg mirtazapine 15mg please provide complete cross titration schedule Specific cross-titration schedules for switching from fluoxetine to mirtazapine are not detailed in available evidence, highlighting the need for clinical judgment based on pharmacokinetic properties and patient factors. |
| title | How should I switch a patient from fluoxetine 40mg to mirtazapine 15mg? Please provide the complete cross-titration schedule. |
| topic | switch patient fluoxetine 40mg mirtazapine 15mg please provide complete cross titration schedule |
| url | https://doi.org/10.5281/zenodo.17998913 |